We analyzed investments made by international pharmaceutical firms in Russia and their contribution to the Russian economy over the period 2006-2016.
Analysis of investments made by International pharmaceutical companies in Russia, 2006-2016
Oncology R&D driving strategic transformation
Putting China's capital to work in the West
Streamlining drug development — at scale
Japan: leading the way in regenerative medicine
Embedding digital into pharma's DNA
Augmenting R&D with artificial intelligence
Value-based healthcare and Value Labs
Life sciences dealmaking expected to continue
Finding sustainability in biotechnology, pharmaceutical and medical technology
Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.
Our Global Life Sciences Network brings together a worldwide team of professionals to help you achieve your potential.
We cover key issues in these areas: